Solvency II requires a new approach to establishing reserves for outstanding claims and premiums. We can guide health insurers in developing the more comprehensive economic capital calculations and enterprise risk management strategies that the new regime requires.
As Solvency II becomes the reporting standard for insurers operating in the region, we provide guidance on best methods for achieving compliance.
We have extensive experience working with health insurers in Western Europe and understand the specific Solvency II issues confronting health insurers operating in each country. We understand the separate Solvency II module for the Netherlands health system, for instance, as well as the special assessment and calculation methods required for German health insurers. We also understand how the differing regulatory and competitive landscape in each country affects an insurer's approach to Solvency II compliance.
We are experienced at determining the optimal approach for health insurers in countries with national mandated healthcare systems, as well as those where healthcare is provided entirely by private insurers.
Our experts are actively involved in the development of Solvency II, and have assisted clients with the quantitative impact studies guiding this regulation's development. With consultants based in markets throughout Western and Southern Europe, we can offer insight into the country-specific Solvency II implementation issues health insurers face.